ArticleEye (London, England)2025
A generalised computer vision model for improved glaucoma screening using fundus images.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- RetinoMamba-AnatomyQuery: Anatomy-Guided Query Learning for Efficient Vision Impairment Screening from Retinal Fundus Images.Life (Basel, Switzerland) · 2026Article
- Hypertuned boosting approach with Local Binary Pattern and Pivot Distribution Count method feature extractor for glaucoma identification.Scientific reports · 2026Article
- Why aren't we using AI in eye clinics? A systematic review of barriers and solutions in AI-based fundus image diagnostics for ocular diseases.International journal of ophthalmology · 2026Review
- Assessing the Efficacy of Synthetic Optic Disc Images for Detecting Glaucomatous Optic Neuropathy Using Deep Learning.Translational vision science & technology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
importanceWorldwide, glaucoma is a leading cause of irreversible blindness. Timely detection is paramount yet challenging, particularly in resource-limited settings. A novel, computer vision-based model for glaucoma screening using fundus images could enhance early and accurate disease detection.
objectiveTo develop and validate a generalised deep-learning-based algorithm for screening glaucoma using fundus image. DESIGN, SETTING AND
participantsThe glaucomatous fundus data were collected from 20 publicly accessible databases worldwide, resulting in 18,468 images from multiple clinical settings, of which 10,900 were classified as healthy and 7568 as glaucoma. All the data were evaluated and downsized to fit the model's input requirements. The potential model was selected from 20 pre-trained models and trained on the whole dataset except Drishti-GS. The best-performing model was further trained to classify healthy and glaucomatous fundus images using Fastai and PyTorch libraries. MAIN OUTCOMES AND MEASURES: The model's performance was compared against the actual class using the area under the receiver operating characteristic (AUROC), sensitivity, specificity, accuracy, precision and the F1-score.
resultsThe high discriminative ability of the best-performing model was evaluated on a dataset comprising 1364 glaucomatous discs and 2047 healthy discs. The model reflected robust performance metrics, with an AUROC of 0.9920 (95% CI: 0.9920-0.9921) for both the glaucoma and healthy classes. The sensitivity, specificity, accuracy, precision, recall and F1-scores were consistently higher than 0.9530 for both classes. The model performed well on an external validation set of the Drishti-GS dataset, with an AUROC of 0.8751 and an accuracy of 0.8713. CONCLUSIONS AND RELEVANCE: This study demonstrated the high efficacy of our classification model in distinguishing between glaucomatous and healthy discs. However, the model's accuracy slightly dropped when evaluated on unseen data, indicating potential inconsistencies among the datasets-the model needs to be refined and validated on larger, more diverse datasets to ensure reliability and generalisability. Despite this, our model can be utilised for screening glaucoma at the population level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.